John Libbey Eurotext



Information des patients sur les effets indésirables des médicaments Volume 11, numéro 1, Janvier 2015

Service universitaire de médecine générale, 15 rue Ambroise Paré, 42023 Saint-Étienne Cedex -

Background. The decrease of adverse drug effects (ADE) rate is a national concern. Few studies have explored how patients are informed about ADE.

Aims. To understand how patients inform themselves on ADE, stored-information after consultation and knowledge about self-reporting of ADE.

Method. Transversal and descriptive study was conducted from May to July 2013, with outpatients consulting GP in Herault (France).

Results. 400 surveys were operated. About 60% of patients estimated to be enough informed about ADE. Research of information by patient was linked to their young age (p < 0.01), studies level (p = 0.01), professional level (p < 0.01), and female gender (p = 0.01). Health professionals have been the main source of information and the most trusted one, package leaflet as secondly. Internet was the least trusted source. There was no stored information for 85% (684/807) of prescriptions. Especially on cardiovascular drugs and chronic treatments which were less informed (p < 0.01). 92% patients didn't know about self-reporting of ADE but 55% were ready to read it.

Conclusion. Even if patients think they are enough informed about ADE, mainly by health professionals, disparities persist on low level of studies, low socio-professional level, high age, men and chronic treatment. Promoting more securely the information about ADE through Medias, could improve health of vulnerable populations.